These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33136013)

  • 1. Predictive Factors for the Success of Intratympanic Dexamethasone Treatment of Acute Subjective Tinnitus.
    Oh HS; Lee ES; An YH; Shim HJ
    J Int Adv Otol; 2020 Dec; 16(3):338-345. PubMed ID: 33136013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for the outcomes of intratympanic dexamethasone in the treatment of acute subjective tinnitus.
    An YH; Yu KK; Kwak MY; Yoon SW; Shim HJ
    Otol Neurotol; 2014 Sep; 35(8):1330-7. PubMed ID: 25080038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Long-Term Outcome of Intratympanic Dexamethasone Therapy between Acute Noise-Induced Tinnitus and Acute Idiopathic Tinnitus.
    Shim HJ; Lee ES; An YH; Kim DH
    J Int Adv Otol; 2017 Apr; 13(1):53-60. PubMed ID: 28084998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic dexamethasone injection effects on transient-evoked otoacoustic emission.
    Yilmaz I; Yilmazer C; Erkan AN; Aslan SG; Ozluoglu LN
    Am J Otolaryngol; 2005; 26(2):113-7. PubMed ID: 15742264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Adding Lidocaine to Dexamethasone in the Intra-tympanic Injection for Management of Tinnitus: A Prospective, Randomized, Controlled Double-blinded Trial.
    Elzayat S; Ragab S; Eisa M; Amer M; Mandour MF; Mehraz M
    Int Tinnitus J; 2018 Jun; 22(1):54-59. PubMed ID: 29993218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effect of intratympanic dexamethasone injection in acute unilateral tinnitus: A prospective, placebo-controlled, multicenter study.
    Lee HJ; Kim MB; Yoo SY; Park SN; Nam EC; Moon IS; Lee HK
    Laryngoscope; 2018 Jan; 128(1):184-188. PubMed ID: 28224644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tinnitus: Evaluation of Intratympanic Injection of Combined Lidocaine and Corticosteroids.
    Elzayat S; El-Sherif H; Hegazy H; Gabr T; El-Tahan AR
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(3):159-66. PubMed ID: 27245783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intratympanic dexamethasone therapy and hyperbaric oxygen therapy for the salvage treatment of refractory high-frequency sudden sensorineural hearing loss.
    Sun H; Qiu X; Hu J; Ma Z
    Am J Otolaryngol; 2018; 39(5):531-535. PubMed ID: 29891394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone: A Randomized Controlled Study.
    Marshak T; Steiner M; Kaminer M; Levy L; Shupak A
    Otolaryngol Head Neck Surg; 2014 Jun; 150(6):983-90. PubMed ID: 24618499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on relationship between distortion product otoacoustic emissions and therapeutic effects in tinnitus].
    Zhang J; Zhou H; Xu Y; Zhang G
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jul; 23(13):591-3. PubMed ID: 19894493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy of Intratympanic Steroid Injection in Tinnitus Cases Unresponsive to Medical Treatment.
    Yener HM; Sarı E; Aslan M; Yollu U; Gözen ED; İnci E
    J Int Adv Otol; 2020 Aug; 16(2):197-200. PubMed ID: 32784157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cochlear function in patients with normal hearing and tinnitus: a distortion product otoacoustic emission study.
    Satar B; Kapkin O; Ozkaptan Y
    Kulak Burun Bogaz Ihtis Derg; 2003 May; 10(5):177-82. PubMed ID: 12970589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Otoacoustic emissions and persistent tinnitus after acute acoustic trauma.
    Nottet JB; Moulin A; Brossard N; Suc B; Job A
    Laryngoscope; 2006 Jun; 116(6):970-5. PubMed ID: 16735910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Objective evaluation of the effects of intravenous lidocaine on tinnitus.
    Kalcioglu MT; Bayindir T; Erdem T; Ozturan O
    Hear Res; 2005 Jan; 199(1-2):81-8. PubMed ID: 15574302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between tinnitus pitch and parameters of audiometry and distortion product otoacoustic emissions.
    Keppler H; Degeest S; Dhooge I
    J Laryngol Otol; 2017 Nov; 131(11):1017-1025. PubMed ID: 28874221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion product otoacoustic emissions in tinnitus patients.
    Onishi ET; Fukuda Y; Suzuki FA
    Int Tinnitus J; 2004; 10(1):13-6. PubMed ID: 15379342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intratympanic dexamethasone vesus post-auricular subperiosteal injection of methylprednisolone treatment for sudden hearing loss].
    Li DB; Zhou S; Xu WJ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(16):1265-1268. PubMed ID: 29798375
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of distortion product otoacoustic emissions and pure tone audiometry in occupational screening for auditory deficit due to noise exposure.
    Wooles N; Mulheran M; Bray P; Brewster M; Banerjee AR
    J Laryngol Otol; 2015 Dec; 129(12):1174-81. PubMed ID: 26549131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A short term study on the efficacies of intratympanic prednisolone and dexamethasone injection for subjective tinnitus].
    She W; Dai Y; Du X; Chen F; Zhang Q; Jiang P; Cui X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Oct; 22(19):871-3, 877. PubMed ID: 19160857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.